Cinctive Capital Management LP Invests $3.97 Million in Teleflex Incorporated $TFX

Cinctive Capital Management LP acquired a new position in shares of Teleflex Incorporated (NYSE:TFX) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 32,423 shares of the medical technology company’s stock, valued at approximately $3,967,000. Cinctive Capital Management LP owned about 0.07% of Teleflex at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of TFX. Russell Investments Group Ltd. raised its holdings in shares of Teleflex by 23.6% in the second quarter. Russell Investments Group Ltd. now owns 83,388 shares of the medical technology company’s stock worth $9,870,000 after acquiring an additional 15,935 shares during the last quarter. Capital International Investors acquired a new stake in shares of Teleflex during the third quarter valued at $44,851,000. Public Sector Pension Investment Board increased its position in Teleflex by 24.9% during the 3rd quarter. Public Sector Pension Investment Board now owns 188,208 shares of the medical technology company’s stock worth $23,029,000 after purchasing an additional 37,539 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its position in Teleflex by 113.9% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 58,047 shares of the medical technology company’s stock worth $7,366,000 after purchasing an additional 30,912 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its stake in Teleflex by 41.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 123,343 shares of the medical technology company’s stock valued at $15,092,000 after purchasing an additional 36,178 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Stock Down 0.9%

TFX opened at $107.29 on Monday. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $143.32. The firm has a 50 day moving average price of $109.80 and a 200 day moving average price of $117.96. The company has a debt-to-equity ratio of 0.81, a quick ratio of 2.01 and a current ratio of 2.54. The company has a market cap of $4.74 billion, a PE ratio of -5.22, a price-to-earnings-growth ratio of 0.67 and a beta of 0.87.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, February 26th. The medical technology company reported $1.93 earnings per share for the quarter, missing analysts’ consensus estimates of $3.73 by ($1.80). Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. The business had revenue of $569.00 million for the quarter, compared to analyst estimates of $912.57 million. During the same period last year, the firm earned $3.89 earnings per share. The company’s quarterly revenue was down 28.5% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Sell-side analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, March 6th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend is Friday, March 6th. Teleflex’s dividend payout ratio is -6.62%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on TFX. Weiss Ratings restated a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Truist Financial boosted their price objective on shares of Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research report on Thursday, December 18th. Wall Street Zen downgraded shares of Teleflex from a “hold” rating to a “sell” rating in a research note on Saturday, March 7th. Wells Fargo & Company raised their target price on shares of Teleflex from $116.00 to $130.00 and gave the stock an “equal weight” rating in a research report on Friday, February 27th. Finally, Royal Bank Of Canada lifted their target price on shares of Teleflex from $115.00 to $125.00 and gave the stock a “sector perform” rating in a research note on Friday, February 27th. Two equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $140.83.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.